Cargando…
Repurposing of Tranilast for Potential Neuropathic Pain Treatment by Inhibition of Sepiapterin Reductase in the BH(4) Pathway
[Image: see text] Tetrahydrobiopterin (BH(4)) is a cofactor in the production of various signaling molecules including nitric oxide, dopamine, adrenaline, and noradrenaline. BH(4) levels are critical for processes associated with cardiovascular function, inflammation, mood, pain, and neurotransmissi...
Autores principales: | Moore, Benjamin J. R., Islam, Barira, Ward, Sean, Jackson, Olivia, Armitage, Rebecca, Blackburn, Jack, Haider, Shozeb, McHugh, Patrick C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682008/ https://www.ncbi.nlm.nih.gov/pubmed/31460307 http://dx.doi.org/10.1021/acsomega.9b01228 |
Ejemplares similares
-
Sepiapterin reductase: Characteristics and role in diseases
por: Wu, Yao, et al.
Publicado: (2020) -
Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy
por: Cronin, Shane J. F., et al.
Publicado: (2023) -
Sepiapterin reductase gene‐disrupted mice suffer from hypertension with fluctuation and bradycardia
por: Sumi‐Ichinose, Chiho, et al.
Publicado: (2017) -
Leaky splicing variant in sepiapterin reductase deficiency: Are milder cases escaping diagnosis?
por: Nakagama, Yu, et al.
Publicado: (2019) -
Evaluation of the silkworm lemon mutant as an invertebrate animal model for human sepiapterin reductase deficiency
por: Jiang, Guihua, et al.
Publicado: (2020)